JP2019532635A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019532635A5 JP2019532635A5 JP2019515539A JP2019515539A JP2019532635A5 JP 2019532635 A5 JP2019532635 A5 JP 2019532635A5 JP 2019515539 A JP2019515539 A JP 2019515539A JP 2019515539 A JP2019515539 A JP 2019515539A JP 2019532635 A5 JP2019532635 A5 JP 2019532635A5
- Authority
- JP
- Japan
- Prior art keywords
- msc
- ido
- composition
- oncolytic virus
- infected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662396604P | 2016-09-19 | 2016-09-19 | |
| US62/396,604 | 2016-09-19 | ||
| PCT/US2017/052313 WO2018053529A1 (en) | 2016-09-19 | 2017-09-19 | Method of targeting oncolytic viruses to tumors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019532635A JP2019532635A (ja) | 2019-11-14 |
| JP2019532635A5 true JP2019532635A5 (https=) | 2020-10-15 |
| JP7358236B2 JP7358236B2 (ja) | 2023-10-10 |
Family
ID=61619005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019515539A Active JP7358236B2 (ja) | 2016-09-19 | 2017-09-19 | 腫瘍溶解性ウイルスを腫瘍に標的化する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US11607426B2 (https=) |
| EP (2) | EP3515462B1 (https=) |
| JP (1) | JP7358236B2 (https=) |
| CA (1) | CA3037333A1 (https=) |
| WO (1) | WO2018053529A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202004680UA (en) | 2017-11-22 | 2020-06-29 | Mesoblast Int Sarl | Cellular compositions and methods of treatment i |
| AU2020325825B2 (en) * | 2019-08-05 | 2026-02-05 | Mesoblast International Sarl | Cellular compositions comprising viral vectors and methods of treatment |
| KR102233568B1 (ko) * | 2019-12-13 | 2021-03-30 | 주식회사 알바이오 | 항암 바이러스가 도입된 중간엽 줄기세포의 세포 생존능을 향상시키는 방법 |
| CA3188492A1 (en) * | 2020-08-10 | 2022-02-17 | Silviu Itescu | Cellular compositions and methods of treatment |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1879573T3 (pl) | 2005-05-10 | 2013-05-31 | Incyte Holdings Corp | Modulatory 2,3-dioksygenazy indoloaminy i sposoby ich zastosowania |
| US8685728B2 (en) * | 2008-01-31 | 2014-04-01 | Rutgers The State University Of New Jersey | Kit containing stem cells and cytokines for use in attenuating immune responses |
| CA2722159C (en) | 2008-04-24 | 2016-04-05 | Newlink Genetics Corporation | Substituted phenylimidazole compounds and their use as ido inhibitors |
| JP5465720B2 (ja) | 2008-07-08 | 2014-04-09 | インサイト・コーポレイション | インドールアミン２，３−ジオキシゲナーゼの阻害剤としての１，２，５−オキサジアゾール |
| EP2493862B1 (en) | 2009-10-28 | 2016-10-05 | Newlink Genetics Corporation | Imidazole derivatives as ido inhibitors |
| US8597637B1 (en) | 2010-05-18 | 2013-12-03 | Weidong Zhang | Breast cancer therapy using an engineered respiratory syncytial virus |
| DK2931877T3 (da) | 2012-12-14 | 2019-11-04 | Univ Rutgers | Fremgangsmåder, som modulerer stamcellers immunregulerende virkning |
| WO2014160475A1 (en) * | 2013-03-13 | 2014-10-02 | Aboody Karen S | Tropic cell based virotherapy for the treatment of cancer |
| KR20150126623A (ko) | 2013-03-14 | 2015-11-12 | 뉴링크 제네틱스 코퍼레이션 | 트립토판 대사로 인한 면역억제의 억제제로서의 삼환식 화합물 |
| WO2015089280A1 (en) * | 2013-12-11 | 2015-06-18 | The General Hospital Corporation | Stem cell delivered oncolytic herpes simplex virus and methods for treating brain tumors |
-
2017
- 2017-09-19 CA CA3037333A patent/CA3037333A1/en active Pending
- 2017-09-19 EP EP17851803.1A patent/EP3515462B1/en active Active
- 2017-09-19 EP EP23172956.7A patent/EP4268838A3/en active Pending
- 2017-09-19 WO PCT/US2017/052313 patent/WO2018053529A1/en not_active Ceased
- 2017-09-19 US US16/330,858 patent/US11607426B2/en active Active
- 2017-09-19 JP JP2019515539A patent/JP7358236B2/ja active Active
-
2023
- 2023-03-20 US US18/186,869 patent/US20230364147A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Merten et al. | Viral vectors for gene therapy and gene modification approaches | |
| CN106659777A8 (zh) | 免疫原性组合产品 | |
| JP2019532635A5 (https=) | ||
| WO2019040920A8 (en) | PREPARATION OF THERAPEUTIC EXOSOMES USING MEMBRANE PROTEINS | |
| WO2020028751A3 (en) | Aav variants with enhanced tropism | |
| JP2014530010A5 (https=) | ||
| EA201990718A1 (ru) | Векторы аденовируса собачьих | |
| WO2008096831A1 (ja) | 癌の治療剤 | |
| JP2016535009A5 (https=) | ||
| JP2012126742A5 (https=) | ||
| WO2014205579A4 (en) | Modified matrix proteins of vesicular stomatitis virus | |
| JP2015533376A5 (https=) | ||
| JP2011528896A5 (https=) | ||
| JP2017524682A5 (https=) | ||
| WO2008103380A3 (en) | Hepatitis b virus compositions and methods of use | |
| JP2014502156A5 (https=) | ||
| JP2016531927A5 (https=) | ||
| MX382985B (es) | Nuevos virus de tilapia y sus usos | |
| JP2015504897A5 (https=) | ||
| JP2022501055A5 (https=) | ||
| RU2019113989A (ru) | Лекарственное средство | |
| JP2014139185A5 (https=) | ||
| WO2014140166A3 (en) | Vaccine | |
| JP2015044878A5 (https=) | ||
| JP2012526519A5 (https=) |